A1. Novel Agents
Poster Session: Novel Agents
Keith S. Kaye, MD, MPH
Professor of Medicine
Rutgers Robert Wood Johnson Medical School
New Brunswick, NJ, United States
Anita F. Das, PhD
Statistician
Das Consulting
Guerneville, CA, United States
Niels Frimodt-Møller, MD DMSc
Professor
Rigshospitalet
Copenhagen, Hovedstaden, Denmark
Kalpana Gupta, MD
VA Boston, Boston, MA, USA
Boston, Massachusetts, United States
Thomas Lodise, Jr., Pharm.D., PhD
Professor, Pharmacy Practice
Albany College of Pharmacy and Health Sciences
Albany, New York, United States
Anne Santerre Henriksen, PhD
Acting EVP of Clinical Development
Utility Therapeutics
Jyllinge, Hovedstaden, Denmark
Morton Alexander, PhD
Co-Founder
Utility Therapeutics
London, England, United Kingdom
Florian Wagenlehner, MD
Justuf Liebeg University Diessen
Diessen, Hessen, Germany